Normal unmedicated human sleep is characterized by electroencephalogram (EEG), continuously recorded throughout the night, into four stages, and a fifth of rapid eye movement sleep (REM) which occurs with increasing frequency and duration as the night progresses. During REM sleep, breathing is irregular and physiological control mechanisms are disturbed when compared with their activity during wakefulness. Thus, even in normal healthy subjects, minute ventilation is decreased in REM sleep, as are both hypoxic and CO2 drives for breathing (Douglas et al. 1982 ). In the Rayne Laboratory of the Department of Respiratory Medicine at the University of Edinburgh, studies have been carried out on breathing patterns (by respiratory inductive plethysmography), ear oxygen saturation (Hewlett Packard Ear Oximeter), air flow at nose and mouth, and EEG continuously throughout the night in subjects sleeping in a quiet, darkened, air-conditioned and sound-proofed room. Particular attention has been paid to sleep hypoxaemia, as shown as episodes when the ear oxygen saturation (reflecting the arterial saturation) falls by at least 10% from the preexisting values during stable sleep, in subjects who are older, have sleep apnoea syndromes, and with chronic bronchitis and emphysema.
(1 kPa = 7.5 mmHg) in arterial samples drawn at the times indicated. (Reproduced from Flenley 1985) suspicion may be strengthened by the finding of recurrent episodes of bradycardia during a 'normal' night's sleep, as recorded by continuous taperecording of ECG (Guilleminault et al. 1984) . However, definitive diagnosis depends upon a sleep study, with recognition of the recurrent, frequent, apnoeic episodes, coupled with transient hypoxaemia, so that the ear oxygen saturation repeatedly falls by at least 4-10% many times per hour of sleep. Early treatment of sleep apnoea should include weight reduction, which even if modest may dramatically improve both symptoms and signs, but if this is not successful continuous positive airway pressure can be very effective (Sullivan et al. 1981) . If this fails, permanent tracheostomyopen only at nightor uveopalatopharyngoplasty may be considered.
Transient nocturnal hypoxaemia associated with REM sleep is now widely recognized to occur in the 'blue and bloated' pattern of patients with chronic bronchitis and emphysema (Douglas et al. 1979;  Figure 1 ). These dramatic falls in arterial oxygen saturation are probably due to falls in arterial oxygen of 10-20 mmHg during REM sleep. It now appears that such falls in arterial Po2 in REM sleep also occur both in normal healthy adults and in 'pink puffers' and 'blue bloaters'; but it is only in the latter that profound falls in arterial oxygen saturation occur, due to the lower level on the oxygen dissociation curve which these patients have even when awake (Catterall et al. 1983) . 'Blue bloaters', of course, are characterized by fixed airways obstruction (FEV1 < 1.21), arterial hypoxaemia and CO2 retention even when awake, with raised pulmonary arterial pressure, cor pulmonale and secondary polycythaemia. Such patients have a grave prognosis, only 30% being alive three years after the diagnosis of cor pulmonale is established. However, such patients can have their prognosis improved by longterm oxygen therapy, which has now been shown by two controlled trials to prolong life (Nocturnal Oxygen Therapy Trial Group 1980 , Medical Research Council Working Party 1981 .
The nocturnal hypoxaemia in REM in these patients is associated with further pulmonary hypertension, and this can also be reversed by nocturnal oxygen, as can the hypoxaemia (Fletcher & Levin 1984) . These observations lead to the postulate (yet to be proven) that the lethal cor pulmonale which such patients develop arises from recurrent pulmonary vasoconstriction associated with the hypoxia during sleep. The hypoxaemic episodes appear to be due to hypoventilation in REM sleep, for they can be reproduced in healthy subjects, who thereby show the transient fall in Po2 without a concomitant rise in Pco2 which is known to characterize these abnormalities in REM sleep in 'blue bloaters'.
In addition to long-term oxygen therapy, the French ventilatory stimulant almitrine has recently been shown in a double-blind crossover study to correct transient hypoxaemia (Connaughton et al. 1985) .
It has now become apparent that an obstructive sleep apnoea syndrome can coincide in an individual patient with chronic bronchitis and emphysema. Such patients are prone to severe hypoxaemia during REM sleep, in addition to persistent hypoxaemic episodes from the obstructive sleep apnoea. Although nocturnal oxygen appears to be relatively free of dangerous further elevation in arterial Pco2 during sleep in simple 'blue bloaters', such patients combining the 'blue and bloated' syndrome with obstructive sleep apnoea (recently named the 'overlap syndrome') do have further elevation of pulmonary arterial pressure and Pco2 during sleep (Goldstein et al. 1984) .
Further proof of the existence of the 'overlap syndrome' is provided by J Brown and E C Fletcher (unpublished observations, 1984) who have shown that tracheostomy will revc. .e the transient hypoxaemia which occurs between REM periods in such a patient due to the obstruction sleep apnoea, but that the addition of nocturnal oxygen therapy to permanent tracheostomy is required to relieve completely the hypoxaemia in both REM and non-REM sleep in such patients with the 'overlap syndrome'. The clinical clue to the presence of this new syndrome is of course obesity, coupled with a history of snoring and possibly sleep disturbance in a patient with irreversible air flow obstruction due to chronic bronchitis and emphysema.
Nocturnal hypoxaemia is also recognized to occurto a much less serious degree than in chronic bronchitis and emphysema -in nocturnal asthma, a pattern of symptoms which is receiving increasing attention, as its frequency is becoming more widely appreciated.
